Salina Thetford
Family · Idaho Falls, IDNPI 1023837390
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,258 of the $2,524 with a category attached, or 89.5%. It is spread thinly across 36 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$242
- AbbVie$191
- AstraZeneca$189
- Tersera Therapeutics LLC$158
- Daiichi Sankyo Inc.$144
- Sobi, Inc$138
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,25889%
- Education$26611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $242 |
| AbbVie | 8 | $191 |
| AstraZeneca | 8 | $189 |
| Tersera Therapeutics LLC | 7 | $158 |
| Daiichi Sankyo Inc. | 7 | $144 |
| Sobi, Inc | 4 | $138 |
| Pfizer | 8 | $123 |
| Novartis | 6 | $117 |
| Lilly USA, LLC | 3 | $105 |
| Seagen Inc. | 1 | $100 |
| Myriad Genetic Laboratories, Inc. | 1 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Genentech USA, Inc. | 3 | $74 |
| Geron Corporation | 3 | $73 |
| Dendreon Pharmaceuticals LLC | 3 | $62 |
| Iovance Biotherapeutics, Inc. | 2 | $56 |
| Merck | 2 | $47 |
| Servier Pharmaceuticals LLC | 2 | $46 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
| Bayer | 2 | $39 |
| GSK | 2 | $34 |
| Legend Biotech USA Inc. | 1 | $33 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Boehringer Ingelheim | 1 | $30 |
| Stemline Therapeutics Inc. | 1 | $24 |
| Medtronic | 1 | $24 |
| Sanofi | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
How this compares
$2,524 in reported general payments places this provider in the 85th percentile of 809 family providers in Idaho.
Other family in Idaho Falls
- Amber MasseIdaho Falls$17K
- Samantha de Bruyn KopsIdaho Falls$10K
- Paula SanderlinIdaho Falls$10K
- Sunita SigdelIdaho Falls$9K
- Melissa KellyIdaho Falls$7K
- Kelsi RoundsIdaho Falls$6K
- Daniel HuntingIdaho Falls$6K
- Sunny RaichartIdaho Falls$5K
- Derek WhitmillIdaho Falls$5K
- Malinda McReaIdaho Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.